FDA Recalls Common Heart Drug for Potential Cancer Risk

FDA Recalls Common Heart Drug for Potential Cancer Risk
By Janita Kan, Writer
Updated:
A common drug used to treat certain heart conditions is being recalled by the U.S. Food and Drug Administration because the drug contains a chemical that poses a potential cancer threat, according to a statement released on July 13.

The FDA said the recall affects several drugs products containing the active ingredient valsartan following the detection of an impurity found in the products. Valsartan is used to treat high blood pressure and heart failure. However, not all medication containing the ingredient is affected by the recall.